Pharmalicensing provides a central meeting point for potential partners from all around the world. Whether you are looking to in- or out-license, your profile allows interested parties to contact you directly with solutions that match your needs.
As part of the Company Profiling subscription, you will be able to:
By upgrading to managed Profiling+ for only $1,000:
Contact:
| Mark McBride | Director |
Maximize your potential for finding the most suitable partner
Actively working for you, our service enables you to utilise the knowledge and expertise of the Pharmalicensing team.
Our Partnering Search service is a fully comprehensive solution designed to complement your existing business development activities.
The Partnering Search service:
Contact:
| Mark McBride | Director |
Our focused reports cover a wide range of topics from a wide range of publishers to help you find the right report.
Topics include:
Publishers include:
Contact:
| Mark McBride | Director |
Personalised Homepage
Your personalised PL Intelligence homepage gathers all of the elements of your subscription in one place and can be tailored to your requirements by selecting up to 3 categories that are of specific interest to you. Once you have chosen your categories your homepage will display the latest information according to the filters you have applied.
For example, if you select 'oncology' your homepage will display oncology related reports, oncology related press releases etc.
Your filters can easily be changed or removed for ultimate flexibility.
Industry news
Our Industry news section provides you with up to date news at your fingertips; searchable by keyword, category and therapeutic target.
News items are linked to company profiles, where relevant.
Deals review
Our Deals review gathers deal information into one place, saving you time and money by gathering industry intelligence and providing data to help you to benchmark your deals.
Deals data is linked to company profiles, where relevant.
Press releases
With an international audience of over 150,000 visitors each month, Pharmalicensing is the perfect place to publish your press releases.
A PL Intelligence subscription allows you to submit an unlimited number of press releases via a simple form.
Reports
Covering a magnitude of biopharmaceutical topics from licensing processes to management strategies and therapeutic overviews; the Pharmalicensing Biopharma Reports Store offers a diverse collection of biopharma and pharmaceutical reports to support and improve your life science decisions.
A PL Intelligence subscription entitles you to an amazing 10% discount on all reports purchased through the store.
Our reports store is fully searchable by category, keyword and publisher to direct you to the report that best matches your requirements.
Additional Benefits:
Articles: Ever wanted to get an article published? With a PL Intelligence subscription your opinions could be broadcast to our audience of over 150,000 unique visitors each month in our Articles section.
Client Care Support: At Pharmalicensing we are committed to ensuring our clients reap the utmost benefit from our services. That is why our Client Care team are close-at-hand to offer help and guidance throughout your subscription. This is why our Client Care team are readily available to offer any help and guidance which you may require.
Unlocking Information: A PL Intelligence subscription unlocks additional information on company profiles, where available.
Contact:
| Mark McBride | Director |
Negotiating a deal can be a complex process requiring time, equal consideration for both parties and a thorough understanding of the contract and its terms. With many pivotal issues to consider it is vital that you have the correct knowledge to move confidently through the negotiation process to achieve the perfect deal.
Pharmalicensing now offers expert support to assist and guide you through the entire deal negotiation process. From the moment you select your partner, Pharmalicensing can help you with initial discussions, preparation of introductory material and suitable deal structure implementation, amongst other things.
Based upon the experience and completion of many real life successful deals, Pharmalicensing provides the appropriate commercial support you require, whatever stage of the process you are at.
Support services include:
Our services are available as a complete package or can be selected as single blocks depending on what stage you need them during the deal making process.
Examples of recent projects:
Contact:
| Mark McBride | Director |
| Mark McBride | Director |
UTEK Corporation Acquires Pharmalicensing, Ltd. (4 Jan 2008)
UTEK Corporation (LSE-AIM & AMEX:UTK), an open innovation company focused on technology transfer, has completed acquisition of Pharmalicensing, Ltd.
Pharmalicensing launches 3rd edition of top selling licensing agreement report (25 Jul 2007)
Today Pharmalicensing launches the 3rd edition of its top selling report 'The Licensing Agreement in Pharmaceutical Business Development'.
Comprehensive consultancy support for your licensing (23 Jul 2007)
Pharmalicensing now offers in-depth and involved consulting to guide you through the process of licensing
New report from Pharmalicensing highlights the R&D opportunities in China (15 Jan 2007)
York, UK, 15 Jan 2006 - Pharmaceutical research and development in China is being constantly accelerated by successful clinical trials, a growing number of established R&D specialist companies and scientific technical expertise
Pharmalicensing's latest report reveals new early stage dealmaking trends (1 Dec 2006)
With deals increasing in terms of number and value, partnering at early stage development is now an integral component of pharmaceutical and biotech business strategy. Pharmalicensing has revised and updated its successful Early Stage report
Pharmalicensing is a division of UTEK Corporation; a business development company that has created a progressive open innovation business model to help companies grow rapidly with university, research laboratory and corporate technology.
Pharmalicensing is the leading global marketplace for life sciences business development and licensing and is utilised by over 150, 000 users per month.
Licensing
For licensors - we help innovators market their licensing opportunities to decision makers at licensee organisations worldwide, including bigpharma, biotech companies, spin-offs and academic institutions.
For licensees - we facilitate global pharmaceutical/ biotechnology companies, investors, and research organisations in identifying, tracking and securing of technology opportunities, actively communicating licensing needs, and forming better partnerships.
In addition, we offer a comprehensive partner search, providing clients with a bespoke prospect list of partner search companies entirely based on their partnering criteria. Following client approval this prospect list can then be converted to a ‘hot list' where we will actively introduce our clients, using the Pharmalicensing name, to one another to begin initial discussions.
For outsourced service providers - we market service providers, their skills and expertise to decision makers in pharmaceutical/biotechnology companies worldwide. This industry is becoming increasingly reliant on the expertise of third parties, in order to reduce the time to market and provide access to know-how worldwide.
Pharmalicensing provides a unique approach to business development:
Listing industry news, timely biopharma reports and details of forthcoming licensing and partnering events, Pharmalicensing provides its users with the relevant mix of intelligence they require in order to strengthen and progress their business development activities further.
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
